Cargando…
HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms
BACKGROUND: Thrombotic diseases are a group of prevalent and life-threatening diseases. Selective inhibition of pathological thrombosis holds the key to treat variety of thrombotic diseases. The pathological thrombosis can be induced by either tissue necrosis and deregulated inflammation. HMGB1, as...
Autores principales: | Yang, Xinyu, Wang, Haichao, Zhang, Menmen, Liu, Jin, Lv, Ben, Chen, Fangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527107/ https://www.ncbi.nlm.nih.gov/pubmed/26245198 http://dx.doi.org/10.1186/s13000-015-0348-3 |
Ejemplares similares
-
Retraction Note: HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms
por: Yang, Xinyu, et al.
Publicado: (2018) -
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009) -
NO inhibits platelet apoptosis by cGMP-dependent and-independent pathways
por: Rukoyatkina, Natalia, et al.
Publicado: (2009) -
PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis
por: Lopes-Pires, M. Elisa, et al.
Publicado: (2015) -
Real-time imaging of cGMP signals in platelets
por: Wen, Lai, et al.
Publicado: (2015)